Markus Schliffka is a postdoctoral researcher in the URPP Human Reproduction Reloaded | H2R, SP4 - CRISPR Technology in Human Reproduction at the University of Zürich.

Markus’ research focuses on harnessing CRISPR technologies for their potential use in elucidating early embryo development. He is a member of the Cavazza Lab at the Department of Reproductive Endocrinology of the University of Zürich.

Education

• PhD in Cell and Developmental Biology, Institut Curie, Paris, France (2023)
• MSc in Biochemistry, Freie Universität Berlin, Germany (2018)
• BSc in Biochemistry, Freie Universität Berlin, Germany (2016)

Work and research experience

• Postdoctoral Researcher at Cavazza lab at the Department of Reproductive Endocrinology, University Hospital Zurich / University of Zurich, Zurich, Switzerland (2024-2026)

• Postdoctoral Researcher at Maître lab, Institut Curie, Paris, France (2023-2024)

• PhD student at Maître lab, Institut Curie, Paris, France (2019-2023)